Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview

23847studies shown

Showing 20,893-20,904 of 23,847

Drug study icon

CompletedNCT00640601

Study Evaluating the Clinical Benefit of SEROQUEL XR in Subjects With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Garran

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: Australia, Canada, China, ...
Sponsor: AstraZeneca
Condition: Schizophrenia

Drug study icon

WithdrawnNCT00892021

Study Evaluating the Effects of Multiple Doses of NSA-789 in Subjects With Schizophrenia or Schizoaffective Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In Rockville

SchizophreniaDrugFrom 18 Years to 50 Years

Countries: United States
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Condition: Schizophrenia

Drug study icon

WithdrawnNCT00781794

Study Evaluating The Effects Of Single Oral Doses Of NSA-789 On Auditory P50 Suppression In Schizophrenic Patients

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Glendale

SchizophreniaDrugFrom 18 Years to 55 Years

Countries: United States, France
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Condition: Schizophrenia

Drug study icon

CompletedNCT00556959

Study Evaluating the Safety and Efficacy of CLONICEL® to Treat Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)

This study is completed in the United States. It focuses on ADHD.

Multiple locations, including Gainesville

ADHDDrugFrom 6 Years to 17 Years

Countries: United States
Sponsor: Addrenex Pharmaceuticals, Inc.
Condition: ADHD

Drug study icon

CompletedNCT01268124

Study Evaluating The Safety and Tolerability of HTC-867 in Healthy Japanese Subjects

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed

SchizophreniaDrugFrom 20 Years to 45 Years

Countries
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Condition: Schizophrenia

Drug study icon

CompletedNCT00406315

Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To Ziprasidone

This study is completed in the United States, in Brazil, in Germany, .... It focuses on Schizophrenia.

Multiple locations, including Phoenix

SchizophreniaDrugFrom 18 Years to 55 Years

Countries: United States, Brazil, Germany, ...
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition: Schizophrenia

Drug study icon

CompletedNCT00563706

Study Evaluating Vabicaserin in Subjects With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Little Rock

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States, Canada
Sponsor: Pfizer
Condition: Schizophrenia

Drug study icon

CompletedNCT03769064

Study for Naltrexone on the Abuse Potential of Methylphenidate

This summary needs review. Please check the official study record and contact the research team for details.

In Overland Park

ADHDDrugFrom 18 Years to 45 Years

Countries: United States
Sponsor: Avekshan LLC
Condition: ADHD

Drug study icon

CompletedNCT00982020

Study in Adolescents With Schizophrenia or Bipolarity

This study exists to better understand the safety of this type of care and how manageable it feels in practice. For people living with Bipolarity, that matters because care needs to work in daily life, not just in theory.

Multiple locations, including Lauderhill

Bipolarity, SchizophreniaDrugFrom 13 Years to 17 Years

Countries: United States, Poland, Russia
Sponsor: Eli Lilly and Company
Condition: Bipolarity, Schizophrenia

Other study type icon

CompletedNCT01796509

Study in Intensive Care Follow-up Programme in Improving Long-term Outcomes of ICU Survivors

This summary needs review. Please check the official study record and contact the research team for details.

In Garches

PTSDOtherOver 18 Years

Countries: France
Sponsor: Assistance Publique - Hôpitaux de Paris
Condition: PTSD

Drug study icon

CompletedNCT04221230

Study in Major Depressive Disorder With NMRA-335140 (BTRX-335140) vs Placebo

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Phoenix

DepressionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Neumora Therapeutics, Inc.
Condition: Depression

Drug study icon

TerminatedNCT00660595

Study in Schizophrenic In-patients Treated With Quetiapine Prolong or Oral Risperidone at Flexible Dose

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Harjavalta

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: Finland
Sponsor: AstraZeneca
Condition: Schizophrenia

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.